Important note

This AI stock analysis for Schrodinger is not up to date. Creating and accessing our AI stock Analysis (powered by our data and Chat GPT) is only available for our premium users. Sign up to get access today!


Schrodinger - AI Stock Analysis

Analysis generated January 30, 2025

Schrodinger is a leading provider of advanced molecular simulations and computational drug discovery tools. The company leverages state-of-the-art technology to assist pharmaceutical companies in accelerating the drug discovery process, lowering costs, and increasing the likelihood of successful drug development. The company combines a robust software platform with deep domain expertise to provide comprehensive solutions in pharmaceuticals, materials science, and other industries.

Fundamental Analysis

Revenue for the last quarter was $35 million. This represents a decrease of 25.44% compared to the quarter before it, indicating a need for concern. However, compared to the same quarter last year, there is a decrease of 17.10%, which also suggests potential weakness in revenue generation, a critical factor for growth.

Net income for the last quarter was $38 million. This is an increase of 29.44% compared to the quarter before it, which is a positive sign of growth. Compared to the same quarter last year, there is an increase of 38.51%, suggesting significant year-over-year growth and efficiency in managing expenses and improving profitability.

EBITDA for the last quarter was $67 million. This represents a decrease of 30.27% compared to the quarter before it and a significant decrease of 65.51% compared to the same quarter last year. Such downturns in EBITDA raise concerns about operational efficiency and profitability.

The current Price-to-Earnings (P/E) ratio is 46.78, which may be considered high. This could potentially indicate overvaluation, aligning with a bearish outlook if growth metrics don't consistently show strong improvement.

Technical Analysis

Today's stock price is $25.43, showing an increase of 35.12% compared to a month ago. This indicates a strong, positive short-term trend. However, the stock price has decreased by 3.86% over the last year, suggesting long-term concerns.

The trend appears bullish as the current 10-day Simple Moving Average (SMA10) is $24.41, which is higher than the previous SMA10 of $23.76, indicating potential upward momentum in price movement. The Relative Strength Index (RSI) is 59.3, which indicates a neutral condition, providing neither a strong buy nor sell signal.

Alternative Data Analysis

Schrodinger currently has 34 open positions according to data from the most popular job boards. This number is down by 8% over the last couple of months, signaling a potential effort to improve margins or cut costs, which is not typical for a growing company. However, the business outlook among employees is very high, with 83% expressing a positive outlook. This optimistic sentiment has trended up by 6% over the last couple of months.

The company has an estimated 85,000 visitors to its webpage. This number is down by 27% recently, which might indicate a drop in customer interest or acquisition. Conversely, Schrodinger's Instagram page has 1,300 followers, and this number has increased by 17% over a few months, indicating enhanced interest in the company's social media presence.

According to AltIndex's AI score, which predicts a company's stock price based on an integrated analysis, Schrodinger has a score of 60. This score suggests a hold signal.

Conclusion and Recommendation

Schrodinger presents a mixed outlook based on the available data. On the one hand, the company shows strong net income growth and positive employee sentiment. On the other hand, decreasing revenue, EBITDA, and web traffic pose significant concerns.

The stock's short-term technical indicators may reflect a bullish trend, but long-term price performance remains underwhelming. Alternative data also provides mixed signals, with declining job postings and web traffic contrasted by rising social media engagement and positive employee outlook.

Based on the gathered data, the recommendation is to hold. The favorable short-term trends and positive sentiment are offset by significant long-term challenges and fundamentals. Investors should closely monitor upcoming earnings reports and operational efficiency metrics before making any long-term commitments.

Disclaimer: This AI stock analysis, generated by an experimental AI tool, is for informational purposes only and not financial advice. Information is based on publicly available data and may not always be accurate or current.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2025 AltIndex. All rights reserved.